Reporter brief
RCT of metformin for sarcopenia prevention in older adults with prediabetes showed no reported effect size
What happened
This RCT examined whether metformin could prevent sarcopenia in older adults with prediabetes. The study was motivated by evidence that insulin resistance increases sarcopenia risk in older people. No effect size or outcomes data were reported in the abstract.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Rct; Human.
Not recorded.
- Design
- Rct
- Sample
- —
- Journal
- VA Office of Research and Development
- Published
- Feb 11, 2020
Effect size
Not recorded.
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Metformin timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.